Review of Targeted Therapy, Vismodegib, for the Treatment of Periocular Basal Cell Carcinoma: Erratum

In Table 1, the column headings in the second portion of the table were incorrect. The column headings have now been corrected. The authors and publisher regret this error.

Singalavanija T, Ceylanoglu KS, Juntipwong S, et al. Review of targeted therapy, Vismodegib, for the treatment of periocular basal cell carcinoma. Ophthalmic Plast Reconstr Surg. 2023 Aug 8 [published online ahead of print].

留言 (0)

沒有登入
gif